Clinical Trials Directory

Trials / Completed

CompletedNCT00758758

Performance of the Hedrocel(R) Cervical Fusion Device

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
231 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The objective of this clinical investigation is to compare patients treated with Anterior Cervical Discectomy and Fusion (ACDF) using the Hedrocel Cervical Fusion Device, with a concurrent, randomized, control group receiving autologous iliac crest bone graft or allograft and test the hypothesis that ACDF with Hedrocel is non-inferior to ACDF with allograft or autologous bone graft.

Detailed description

The objective of this clinical investigation is to compare patients treated with Anterior Cervical Discectomy and Fusion (ACDF) using the Hedrocel Cervical Fusion Device, with a concurrent, randomized, control group receiving autologous iliac crest bone graft. Success criteria include radiographic evidence of fusion, and improvement in pain, function and overall quality of life. If shown to be successful, the use of the Hedrocel Cervical Fusion Device would eliminate complications associated with harvesting autologous bone graft and provide an alternative for those who are unable to provide autologous bone graft from the iliac crest.

Conditions

Interventions

TypeNameDescription
DEVICEAnterior Cervical Discectomy and FusionImplantation of Hedrocel
DEVICEAnterior Cervical Discectomy and FusionImplantation of Allograft
DEVICEAnterior Cervical Discectomy and FusionImplantation of Autograft

Timeline

Start date
2001-12-01
Primary completion
2009-01-01
Completion
2009-06-01
First posted
2008-09-25
Last updated
2013-08-23
Results posted
2013-08-12

Locations

13 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00758758. Inclusion in this directory is not an endorsement.